arBtrage CAPITALIZING MARKETS checking… Sign in

Protara Therapeutics, Inc.

TARA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$4.16
▼ -5.7% Today
as of Jun 7, 07:29 ET
Last 30 days -17.79% Apr 28 → Jun 05
$4.04 $4.47 $4.91 $5.34 $5.78 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.43
High
$4.43
Low
$4.13
Volume
$439,826
Avg Vol
$706,198
Mkt Cap
$267M
P/E (TTM)
Beta
52w High
$7.82
52w Low
$2.77
Div Yield
Shares Out
$55M

Overview

52-week range
$2.77
$7.82
28% of range
Avg surprise (last 2)
+26.1%
Avg reaction (last 2)
+0.8%
100% positive
Latest IV / EM
286%
EM ±39.7% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.00$-0.82$-0.65$-0.47$-0.29 Actual $-1.00Actual $-0.87Actual $-0.97Actual $-0.45Actual $-0.50Actual $-0.29Est $-0.47Actual $-0.35Actual $-0.31Actual $-0.31Est $-0.36 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-18M$-16M$-14M$-12M$-10M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.31 $-0.36 +13.9% -6.9% +1.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.31 financials
Mon Jun 30, 2025Jun 2025 $-0.35 financials
Thu May 8, 2025Mar/2025 $-0.29 $-0.47 +38.3% +0.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.50 financials
Sun Jun 30, 2024Jun 2024 $-0.45 financials
Sun Mar 31, 2024Mar 2024 $-0.97 financials
Sat Sep 30, 2023Sep 2023 $-0.87 financials
Fri Jun 30, 2023Jun 2023 $-1.00 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-20M$-15M$-17M$-14M$-12M$-11M
Net income$-18M$-13M$-15M$-12M$-11M$-10M
EPS (diluted)$-0.31$-0.31$-0.35$-0.29$-0.50$-0.45

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$15M$50M$13M$31M$91M$163M$52M$90M
Inventory
Total current assets$140M$160M$136M$125M$127M$172M$85M$92M
Total assets$192M$209M$145M$157M$169M$181M$94M$102M
Long-term debt
Total liabilities$11M$13M$12M$13M$10M$14M$12M$10M
Total equity$181M$196M$132M$144M$158M$167M$82M$92M

Implied volatility — last 90 days

281%283%286%288%291% Jun 07 — IV 286% · EM ±39.7%

Sector peers